Overview
Emily Duffield is a Nurse Practitioner in New Haven, Connecticut. Ms. Duffield is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 York St, New Haven, CT 06510
Yale University
Marianne Davies is a Nurse Practitioner in New Haven, Connecticut. Ms. Davies is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Upper Tract Urothelial Carcinoma (UTUC).
University Of Connecticut Health Center
Kathryn Medow is a Nurse Practitioner in Farmington, Connecticut. Ms. Medow is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Pediatric Low-Grade Glioma (pLGG), and Neurofibromatosis Type 1 (NF1).
Yale University
Vanna Dest is a Nurse Practitioner in New Haven, Connecticut. Ms. Dest is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerMs. Duffield isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.